ClinicalTrials.Veeva

Menu

Screening Of Adult urBan pOpulation To diAgnose Heart Failure (SOBOTA-HF)

G

General Hospital Murska Sobota

Status

Unknown

Conditions

Heart Failure

Treatments

Diagnostic Test: NT-proBNP, echocardiography

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03526601
SBMS001

Details and patient eligibility

About

Screening Of adult urBan pOpulation To diAgnose Heart Failure (SOBOTA-HF) is a cross-sectional prevalence study in a representative sample of Murska Sobota residents aged 55 years or more. Individuals will be invited to participate in a screening with NT-proBNP. All subjects with NT-proBNP ≥ 125 pg/mL will be invited for a diagnostic visit that will include history and physical examination, electrocardiogram, echocardiography, ankle brachial index, pulmonary function tests, body composition measurement, physical performance tests and questionnaires. To validate the screening procedure, a control group (NT-proBNP < 125 pg/mL) will undergo same diagnostic evaluation. An external center will validate echodardiography exams and the HF diagnosis will be adjudicated within an independent HF expert panel. Overall and age specific HF prevalence will be calculated in individuals ≥ 55 years and extrapolated to the whole population.

Enrollment

2,861 estimated patients

Sex

All

Ages

55+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age >55
  • living in Murska Sobota
  • part of representative sample as selected by Statistical Office of the Republic of Slovenia

Exclusion criteria

NONE.

Trial contacts and locations

1

Loading...

Central trial contact

Mitja Lainscak, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems